02.01.24 -- Breaking Down Solid Tumors

To support the treatment options and increasing scale of the industry, flexible, closed, and automated solutions will be necessary when bringing allogeneic cell therapy to patient care.

Review a comparison of the cation exchange and affinity column for the first column step and learn how the new CIMmultus High Reproducibility (HR) line columns are used for the polishing step.

Simplify your workflow and achieve successful protein analysis with a faster, more robust, and highly reproducible alternative method to SDS-PAGE.

Explore a comprehensive translational workflow that includes all the tools essential for elevating your CAR NK cell research and advancing your CAR NK cells to the next level.

Quality by design (QbD) is enormously valuable but often underutilized, siloed, and not operationalized. Discover the benefits of enabling QbD with AI-driven quality operations and batch automation.

An alternative to traditional polyethylene bags is offering cell and gene therapy manufacturers a solution to contamination concerns regarding DNA or RNA fragments.

Plasmids are crucial for CRISPR-Cas9 gene-editing technology and their role is expected to evolve with ongoing research, likely reducing the current limitations, and offering more control and precision.

Success in the gene therapy space requires navigating uncertainties related to the process development and manufacturing of AAV and lentivirus vectors. Use these tips when operating within short timelines.

Learn why failure to include at least some elements of GMP in your cell line design and development process could make it more difficult to get the data required for future IND or BLAs.